GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Stock Based Compensation

InNexus Biotechnology (InNexus Biotechnology) Stock Based Compensation : $0.00 Mil (TTM As of Mar. 2011)


View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Stock Based Compensation?

InNexus Biotechnology's Stock Based Compensation for the three months ended in Mar. 2011 was $0.02 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2011 was $0.00 Mil.


InNexus Biotechnology Stock Based Compensation Historical Data

The historical data trend for InNexus Biotechnology's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Stock Based Compensation Chart

InNexus Biotechnology Annual Data
Trend Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Jun08 Jun09 Jun10
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.91 0.30 -0.04

InNexus Biotechnology Quarterly Data
Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.04 - 0.02 0.02

InNexus Biotechnology Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.


InNexus Biotechnology Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


InNexus Biotechnology (InNexus Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7
InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines